🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
Kelix Bio to acquire five UAE-based pharma entities post Mubadala deal
VCCircle
·
1y ago
Medial
Kelix Bio, a specialty generic biopharmaceutical company, plans to acquire five pharmaceutical entities based in the UAE. The move comes after the company's acquisition by Mubadala Investment Company, Abu Dhabi's sovereign investor. Kelix Bio aims to expand its product portfolio of affordable critical drugs and boost growth in emerging markets.
View Source
Related News
Mubadala acquiring Afro-Indian pharma platform in landmark PE exit for DPI, others
VCCircle
·
1y ago
Medial
Abu Dhabi's Mubadala Investment Company is set to acquire KELIX bio, a pan-African specialty generic biopharmaceutical platform, in a landmark private equity exit and M&A deal. The deal's size was not disclosed, but Mubadala's acquisition is part of its effort to strengthen the development of the UAE's life sciences ecosystem. KELIX bio, established in 2020, develops and sells affordable specialty products across emerging markets. It has a presence in over 50 countries and generated revenues exceeding $150 million. The acquisition is seen as an opportunity for Mubadala to further expand its position in the life sciences sector.
View Source
Kelix bio makes fifth strategic deal since acquisition by Mubadala
VCCircle
·
6m ago
Medial
Kelix Bio, a biopharmaceutical firm focused on emerging markets, has made its fifth strategic acquisition since being acquired by Mubadala Investment Company. The recent acquisition of UAE-based diabetes drug maker DiabTec expands Kelix's portfolio of affordable critical medications. DiabTec's facilities enhance Kelix's manufacturing capabilities. Mubadala's acquisition of Kelix is aligned with its strategy to expand its healthcare platform, supporting the UAE's life sciences sector and diversifying its economy. Kelix operates across several emerging markets, offering various specialty products.
View Source
Mubadala acquiring Afro-Indian pharma platform in landmark PE exit for DPI, others
VCCircle
·
1y ago
Medial
Abu Dhabi's sovereign investor, Mubadala Investment Company, is set to acquire pan-African specialty generic biopharmaceutical platform, KELIX bio, from a consortium of investors. The deal, one of the largest private equity exits and M&A deals in Africa in the last twenty years, will strengthen Mubadala's presence in the life sciences sector. KELIX bio develops and commercialises affordable specialty products for underserved populations in emerging markets. It has an export presence across Africa, Latin America, Southeast Asia, and the Middle East and generates revenues exceeding $150 million.
View Source
Advent-owned Suven Pharma to buy majority stake in NJ Bio for $64 mn
VCCircle
·
7m ago
Medial
Indian contract development and manufacturing organization (CDMO) Suven Pharma, owned by private equity firm Advent International, is set to acquire a majority stake in US-based NJ Bio for $64.4 million. Suven Pharma will purchase a 56% stake in NJ Bio, a technology-driven CDMO specializing in complex drug modalities, at a pre-money valuation of $100 million. The deal will involve a combination of primary and secondary investments, with Suven paying $49.4 million to buy out existing minority shareholders and infusing $15 million in primary equity. The transaction is expected to close this month.
View Source
Grapevine: Mubadala may join hands with Warburg for Shriram Housing; Brookfield eyes Leela Palaces Listing
VCCircle
·
1y ago
Medial
UAE sovereign fund Mubadala is reportedly in talks to partner with Warburg Pincus for the purchase of a majority stake in Shriram Housing Finance, a subsidiary of Shriram Finance. Meanwhile, Brookfield Asset Management is considering listing Leela Palaces as it seeks to expand its hospitality business in India. Mubadala is said to be exploring multiple investment opportunities in the Indian market, while Warburg Pincus and Bain Capital are also contenders for the Shriram Housing Finance deal.
View Source
DPI scores another exit in Africa this year as third PE harvest is in the offing
VCCircle
·
1y ago
Medial
Development Partners International (DPI), a private equity firm specializing in African investments, continues to make strategic exits. DPI recently completed the sale of Kelix Bio and is now working on another exit, aiming to create distributions for its Limited Partners. The firm remains focused on generating value for its investments in Africa and further solidifying its position in the region.
View Source
Mubadala inks deal to invest in Indian healthcare sector
VCCircle
·
1y ago
Medial
Mubadala Investment Company, the sovereign wealth fund of Abu Dhabi, has made a deal to acquire a stake in an Indian healthcare company, marking its return to the Indian market after 18 months. The private equity-style investment signals Mubadala's continued interest in the healthcare sector and its commitment to expanding its portfolio in India.
View Source
Goldman strikes $1 billion private credit deal with Mubadala
Livemint
·
1y ago
Medial
Goldman Sachs has secured a $1 billion partnership with Mubadala Investment to explore private credit opportunities in Asia, with a particular focus on India. The deal comes as investors increasingly seek exposure to the growing private credit market, which has more than doubled in size over the past five years. While Asia-Pacific is less developed in terms of private credit compared to North America and Europe, Goldman Sachs aims to expand its presence in the region. Mubadala, with around $300 billion in assets under management, plans to double its exposure to Asia by 2030.
View Source
GIC-backed AM Green to buy Finnish firm Chempolis, Fortum’s Bio2X
VCCircle
·
9m ago
Medial
Indian energy transition firm AM Green has announced plans to acquire Finnish biorefining company Chempolis and Fortum's biobased solutions business, Bio2X. The company will invest around $1bn over the next three years to create capacity for sustainable aviation fuel. AM Green plans to leverage the acquisition to develop Chempolis' technology into a global bio-refinery platform, enabling decarbonisation in aviation, fuels and chemicals. The company will also work with partners globally to establish a bio-refinery ecosystem. The deal values have not been disclosed.
View Source
Mubadala ties up with Temasek unit Seviora for co-investments
VCCircle
·
8m ago
Medial
Mubadala Capital, the investment arm of Mubadala Investment Company, and Seviora Holdings, a unit of Singapore's state investor Temasek, have announced a collaboration to explore co-investment opportunities. The partnership will involve identifying strategic opportunities that align with their long-term goals, with a specific focus on Singapore and the UAE. Both firms will establish a joint working committee to facilitate this collaboration.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in